Modulation of Mcl-1 transcription by serum deprivation sensitizes cancer cells to cisplatin

This study identifies Mcl-1 as a new target for the sensitization of human cancer cells to cell death by SD, which is of great significance for the development of efficient anti-cancer therapies.